A phase III study of Actos combination drug in diabetic patients
Phase 3
- Conditions
- Diabetes mellitus
- Registration Number
- JPRN-jRCT2080220870
- Lead Sponsor
- Takeda Pharmaceutical Company Limited
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
1.Admission status: Outpatient
2.The subject who applies for participation in this study and is capable of giving written informed consent, reading informed consent form and other study-related documents, and understanding them, etc.
Exclusion Criteria
1.The subject with serious cardiac disease, cerebrovascular disease, or serious pancreatic or hematological disease.
2.The subject is considered ineligible to participate in the study by the investigator or subinvestigator, etc.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method